Single Combined Asthma Inhaler Better Than Recommended Treatment – Medical News Today


Telegraph.co.uk

Single Combined Asthma Inhaler Better Than Recommended Treatment
Medical News Today
Using two asthma medications combined in a single inhaler provides superior rescue and preventive treatment than guideline-based treatments among adults whose asthma symptoms are not well controlled, according to two large, randomized clinical trials
Combo Inhaler May Give Better Relief for Some With AsthmaU.S. News & World Report
Single inhaler asthma therapy betterWebMD.Boots.com
Dual-purpose asthma inhalers more effectiveTelegraph.co.uk
Exchange Morning Post (press release)
all 5 news articles »

View full post on asthma – Google News

AAAAI: Combined OCPs Not Tied to Respiratory Issues – Doctors Lounge


ModernMedicine

AAAAI: Combined OCPs Not Tied to Respiratory Issues
Doctors Lounge
The investigators found that the use of progestin-estrogen OCPs was not associated with lower respiratory tract infections, wheezing, or asthma among offspring. However, progestin-only pill use in the year prior to pregnancy had a slight positive
Moms' Use of 'the Pill' Won't Raise Kids' Asthma Risk: StudyU.S. News & World Report

all 10 news articles »

View full post on asthma – Google News

GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results – FOXBusiness


Proactive Investors USA & Canada

GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results
FOXBusiness
Wednesday that their combined treatment for patients with chronic obstructive pulmonary disorder and asthma posted strong results in a clinical study.
Glaxo, Theravance report Relovair safety dataBusinessWeek
GSK and Theravance announce combination ICS/LABA Phase II results in the MarketWatch (press release)
GlaxoSmithKline and Theravance announce positive phase II results for Relovair Proactive Investors USA & Canada
FierceBiotech –RTT News
all 38 news articles »

View full post on asthma – Google News